Medicine Use in Chronic Diseases.
1Social, Behavioral, and Administrative Sciences, Touro College of Pharmacy, New York, NY 10027, USA.
Pharmacy (Basel, Switzerland)
|June 27, 2023
Summary
This special issue explores medicine use in chronic disease management. It highlights advancements in pharmacy practice and education for better patient outcomes.
Area of Science:
- Pharmacy
- Pharmacology
- Public Health
Background:
- Focuses on the critical role of medication management in chronic disease care.
- Addresses challenges and innovations in pharmacy education and practice.
- Explores the intersection of pharmaceutical sciences and patient well-being.
Discussion:
- Examines current trends in pharmacotherapy for prevalent chronic conditions.
- Discusses the evolving responsibilities of pharmacists in multidisciplinary care teams.
- Highlights the importance of evidence-based medicine use in long-term health management.
Key Insights:
- Emphasizes the need for continuous learning and adaptation in pharmacy practice.
- Showcases innovative approaches to medication adherence and patient counseling.
- Underscores the impact of optimized medicine use on reducing chronic disease burden.
Outlook:
- Predicts future directions in pharmaceutical care for chronic diseases.
- Suggests areas for further research in pharmacogenomics and personalized medicine.
- Encourages interprofessional collaboration to enhance patient care models.
More Related Videos
Related Concept Videos
Chronic Obstructive Pulmonary Disease-V: Management
2.6K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.6K
Chronic Pancreatitis II: Collaborative Care
116
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
116
Chronic Kidney Disease III: Interprofessional Care
48
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
48
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
201
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
201
Chronic Kidney Disease IV: Nursing Management
29
Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
29
Inflammatory Bowel Disease IV: Pharmacological Management
155
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
155


